Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving blood clotting factor
Patent
1995-06-06
2000-06-13
Spiegel, Carol A.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving blood clotting factor
435 71, 435 771, 435 681, 436 69, 530382, 530407, C12Q 156, G01N 3353
Patent
active
060748370
ABSTRACT:
An assay method that requires a soluble fibrin monomer or a soluble fibrin monomer reagent as one of the components of the assay. The reagent is a fibrin-like material having a solubility and stability similar to fibrinogen in that it remains soluble and stable at physiological conditions at a concentration employed in the assay in the absence of fibrin polymerization inhibitors or reagents for maintaining solubility.
REFERENCES:
patent: 4429040 (1984-01-01), Becker et al.
patent: 4647554 (1987-03-01), Jolles et al.
patent: 4818690 (1989-04-01), Paques
Procyk, R. et al, "Disulfide Bond Reduction in Fibrinogen: Calcium Protection and Effect on Clottability", Biochemistry, 1990, 29, pp. 1501-1507.
Roman Procyk et al., Biochemistry, 1992, 31 2273-2278.
Clin. Chem. 32/3, 482-485 (1986).
Kudryk Bohdan J.
Procyk Roman
New York Blood Center Inc.
Spiegel Carol A.
LandOfFree
Assays using a soluble fibrin-like monomer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Assays using a soluble fibrin-like monomer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Assays using a soluble fibrin-like monomer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2067491